Since the introduction of combined antiretroviral therapy (cART) and more effective
treatments for AIDS, there has been a dramatic shift from the weight loss and wasting that …

Background Recent studies have reported weight gain in virologically suppressed persons
living with human immunodeficiency virus (PLWH) switched from older antiretroviral therapy …

Introduction Weight gain following antiretroviral therapy (ART) initiation is common,
potentially predisposing some persons with HIV (PWH) to cardio‐metabolic disease. We …

Exocrine pancreatic disease is thought to be uncommon in clinical practice and usually
secondary to excess alcohol intake. Although excess alcohol intake does account for many …

Background: With the introduction of integrase strand transfer inhibitor (INSTI)-based
antiretroviral therapy, persons living with HIV have a potent new treatment option. Recently …

Background. Weight gain after antiretroviral therapy (ART) initiation is common, but its
implication for mortality is unknown. We evaluated weight change in the first year after ART …

Background Global antiretroviral therapy has entered a new era. Integrase strand transfer
inhibitor (INSTI) has become the first choice in acquired immunodeficiency syndrome (AIDS) …

The twin global epidemics of HIV infection and food scarcity disproportionately affect sub-
Saharan Africa, and a significant proportion of patients who require antiretroviral therapy …

Background. Poor nutritional status is associated with immunologic impairment and adverse
health outcomes among adults infected with human immunodeficiency virus (HIV). Methods …

Abstract Background Sub-Saharan Africa suffers from a high burden of undernutrition,
affecting 23.2% of its population, and in 2015 constituted 69% of the estimated people living …